News Releases: Corporate

  • Thursday February 16, 2017

    Company Ranked No. 2 In Industry Group For 2017

    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company was today named one of the 2017 World’s Most Admired Companies by Fortune Magazine, attaining the rank of No. 2 within the company’s industry sector. “It’s an honor to receive this recognition for the fourth year in a row,” said Hugh Grant, Monsanto Chairman and CEO. “This ranking not only celebrates Monsanto’s pledge to operating with transparency and reporting progress, but also underscores our globalmore...
  • Friday January 27, 2017

    Shareowners Also Reelect 13 Board Members at Company’s Annual Meeting Today

    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) announced that its Board of Directors, at a regularly scheduled meeting held today, declared a quarterly dividend on its common stock of 54 cents per share. The dividend is payable on April 28, 2017, to shareowners of record on April 7, 2017. It relates to the second quarter of the company’s 2017 fiscal year. In other matters, Monsanto shareowners reelected 13 board members to serve new one-year terms endingmore...
  • Thursday January 12, 2017

    Technology Platform Will Help Monsanto Analyze, Store And Mine Its Industry-Leading Broad Genomic Data Sets To Enhance Breeding And R&D Opportunities

    ST. LOUIS & NESS ZIONA, Israel--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) and NRGene announced today that the companies have reached a non-exclusive, multi-year global licensing agreement on NRGene’s genome-analysis technology to enhance Monsanto’s ability to predict, compare and select the best genetic makeup from its vast data sets of genetic, genomic and trait information. NRGene’s platform, GenoMAGICTM, was developed by a unique mix of highly experienced algorithm designers,more...
  • Wednesday January 4, 2017
    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) announced today that it has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture. The CRISPR-Cpf1 system represents an exciting advance in genome-editing technology, because it has potential to be a simpler and more precise tool for making targeted improvements in a cell's DNA when compared to the CRISPR-Cas9more...
  • Thursday December 29, 2016
    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) announced it will issue the company’s financial results for its fiscal 2017 first quarter and annual research and development pipeline update on Thursday, Jan. 5, 2017, prior to market open. Monsanto will hold a conference call starting at 8:30 a.m. Central Time (9:30 a.m. Eastern Time) in conjunction with the announcement of its results. The call will focus on the company’s results for the firstmore...
  • Tuesday December 13, 2016
    • Key Milestone in Merger to Create a Global Leader in Agriculture
    • Close of Transaction Expected by the End of 2017
    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) announced that at a special meeting of shareowners held today, shareowners of the company approved the merger of Monsanto with a wholly owned subsidiary of Bayer Aktiengesellschaft. Under the terms of the merger agreement, Monsanto shareowners will receive $128 per share in cash at the closing of the merger. “We are pleased we received such strong support from our shareowners,” said Hugh Grant, Monsantomore...
  • Monday December 5, 2016
    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) announced that leading independent proxy advisory firms Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) have both recommended that Monsanto shareowners vote “FOR” the proposal to adopt the Agreement and Plan of Merger providing for the acquisition of Monsanto by Bayer Aktiengesellschaft. Under the terms of the merger agreement, which is being submitted to a vote at amore...
  • Tuesday November 22, 2016
    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company’s (NYSE: MON) Robb Fraley, Ph.D., executive vice president and chief technology officer, will present to investors at the Citi Basic Materials Conference in New York, New York on Wednesday, November 30. Fraley will discuss the company’s strategic initiatives, future expectations, R&D pipeline, product performance and other matters related to the company’s business. Fraley’s session will begin at 10:15 a.m. ET (9:15 a.m. CTmore...
  • Tuesday November 8, 2016
    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company’s (NYSE: MON) Pierre Courduroux, senior vice president and chief financial officer, will speak with investors in Boston on Tuesday, November 15 at the Morgan Stanley Global Chemicals and Agriculture Conference. Courduroux will discuss the company’s strategic initiatives, future expectations, product performance and other matters related to the company’s business. Courduroux’s session will begin at 11:00 a.m. ET (10:00 a.m. CTmore...
  • Tuesday November 1, 2016
    ST. LOUIS--(BUSINESS WIRE)--Monsanto Company (NYSE: MON) announced that its Board of Directors has designated Tuesday, December 13, 2016 as the date for a special meeting of shareowners to vote upon the proposal to adopt the merger agreement with Bayer. The special meeting of shareowners will be held at the company’s global R&D headquarters in Chesterfield, Mo. Additional meeting details will be included in the company’s proxy statement, which will bemore...
Keywords: all all Corporate